Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • From the Analyst's Couch
  • Published:

US academic drug discovery

Nature Reviews Drug Discovery volume 10, pages 409–410 (2011)Cite this article

Subjects

Survey and analysis

Seventy-eight units in the United States were identified as small-molecule drug discovery centres sited within universities or non-profit research organizations, and their response rate in our survey was 71%.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Research focus of academic drug discovery centres.
Figure 2: Aggregated depiction of the pipeline by stage for all centres.

References

  1. Wyatt, P. G. The emerging academic drug-discovery sector. Future Med. Chem. 1, 1013–1017 (2009).

    Article  CAS  Google Scholar 

  2. Tralau-Stewart, C. J. et al. Drug discovery: new models for industry–academic partnerships. Drug Discov. Today 14, 95–101 (2009).

    Article  Google Scholar 

  3. Edwards, A. M. et al. Open access chemical and clinical probes to support drug discovery. Nature Chem. Biol. 5, 436–440 (2009).

    Article  CAS  Google Scholar 

  4. Kneller, R. The importance of new companies for drug discovery: origins of a decade of new drugs. Nature Rev. Drug Discov. 9, 867–882 (2010).

    Article  CAS  Google Scholar 

  5. Stevens, A. J. et al. The role of public-sector research in the discovery of drugs and vaccines. N. Engl. J. Med. 364, 535–541 (2011).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Stephen Frye and Rudolph Juliano are at the Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, North Carolina 27599, USA.,

    Stephen Frye & Rudolph Juliano

  2. Marina Crosby and Teresa Edwards are at the Odum Institute for Research in Social Science, University of North Carolina at Chapel Hill, North Carolina 27599, USA.,

    Marina Crosby & Teresa Edwards

Authors
  1. Stephen Frye
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Marina Crosby
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Teresa Edwards
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Rudolph Juliano
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Stephen Frye or Rudolph Juliano.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Supplementary information

Supplementary information Box S1

Survey methodology (PDF 1362 kb)

Supplementary information Figure S2

Additional data from survey questions. (PDF 2060 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Frye, S., Crosby, M., Edwards, T. et al. US academic drug discovery. Nat Rev Drug Discov 10, 409–410 (2011). https://doi.org/10.1038/nrd3462

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrd3462

This article is cited by

Search

Advanced search

Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research